To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Rare Kidney Stone Consortium


Mayo Clinic
200 First St., SW
Rochester, MN 55901





800 Number


Email Address

[email protected]


The Rare Kidney Stone Consortium (RKSC) is funded by a National Institutes of Health (NIH) grant whose primary research aim is to advance understanding of disease expression and the factors associated with renal injury in four rare kidney stone diseases: primary hyperoxaluria (PH), cystinuria, APRT deficiency (APRT) and Dent disease. RKSC’s overall goal is the development of new treatments directed at protecting renal function and reducing nephrocalcinosis and stone formation.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.